BioCatalyst

Trastuzumab deruxtecan, Taxane, Pertuzumab, Trastuzumab — catalyst calendar

1 verified catalyst event(s) referencing Trastuzumab deruxtecan, Taxane, Pertuzumab, Trastuzumab, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-07-06
in 14d
ESTIMATED
 READOUT
Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuz
Phase 3 · Breast Cancer; HER2-positive; Metastatic
 AZN ASTRAZENECA PLC Trastuzumab deruxtecan, Taxane, Pertuzum ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.